Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Study 2016-2026, by Segment (GYR-12, DS-2969, … …), by Market (Bacterial Infections, Clostridium Diffclie Infections, … …), by Company (Abgentis Limited, AstraZeneca Plc, … …)
SKU ID :99ST-14585294 | Published Date: 05-Oct-2019 | No. of pages: 55Description
Summary
The global DNA Gyrase Subunit B (EC 5.99.1.3) market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
GYR-12
DS-2969
VXC-100
VT-12008911
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Bacterial Infections
Clostridium Diffclie Infections
Klebsiella Pneumoniae Infections
Others
Abgentis Limited
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Merck & Co., Inc.
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global DNA Gyrase Subunit B (EC 5.99.1.3) market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
GYR-12
DS-2969
VXC-100
VT-12008911
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Bacterial Infections
Clostridium Diffclie Infections
Klebsiella Pneumoniae Infections
Others
Company Coverage (Sales data, Main Products & Services etc.):
Abgentis Limited
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Merck & Co., Inc.
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now